Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program | MSL WORLD BLOG

Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program

Breaking World Pharma News Add comments
Feb 282011

Genzyme Corporation (NASDAQ: GENZ) recognized International Rare Disease Day with the launch of a new program, the Genzyme Patient Advocacy Leadership Awards (PAL Awards).

Link:
Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program

Posted by Dr. Samuel Dyer at 10:00 pm Tagged with: , , , , , , , , , , , , ,

Leave a Reply

(required)

(required)

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

© 2011 MSL WORLD

Switch to our mobile site